TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T55285	Glycine receptor subunit alpha-1	D0M8AB	Glycine	Approved	750	C2H5NO2	75.07	C(C(=O)O)N	EC50 = 94000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B2VQA3	(1S,6R,8S,11S,13R,16R,17R)-8-Tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,18-dione	Investigative	44420866	C20H26O8	394.4	C[C@@H]1CO[C@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	B2VQA3	(1S,6R,8S,11S,13R,16R,17R)-8-Tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,18-dione	Investigative	44420866	C20H26O8	394.4	C[C@@H]1CO[C@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B2YIL1	(1S,6R,8S,11S,13S,16R,17R)-8-Tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecan-18-one	Investigative	44420867	C20H28O7	380.4	C[C@@H]1CO[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](COC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	B2YIL1	(1S,6R,8S,11S,13S,16R,17R)-8-Tert-butyl-6,17-dihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecan-18-one	Investigative	44420867	C20H28O7	380.4	C[C@@H]1CO[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](COC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B3BO2P	Methyl 2-[(1R,6R,8S,11S,14E)-8-tert-butyl-6-hydroxy-5,15-dioxo-2,4,16-trioxapentacyclo[8.4.2.0^{1,11}.0^{3,7}.0^{7,11}]hexadecan-14-ylidene]propanoate	Investigative	44420862	C21H26O8	406.4	C/C(=C\\1/CC[C@@]23[C@@]14C(=O)OC2C[C@H](C35[C@H](C(=O)OC5O4)O)C(C)(C)C)/C(=O)OC	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	B3BO2P	Methyl 2-[(1R,6R,8S,11S,14E)-8-tert-butyl-6-hydroxy-5,15-dioxo-2,4,16-trioxapentacyclo[8.4.2.0^{1,11}.0^{3,7}.0^{7,11}]hexadecan-14-ylidene]propanoate	Investigative	44420862	C21H26O8	406.4	C/C(=C\\1/CC[C@@]23[C@@]14C(=O)OC2C[C@H](C35[C@H](C(=O)OC5O4)O)C(C)(C)C)/C(=O)OC	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B41KYB	2-[(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-31-(2-Acetyloxyethyl)-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaen-15-yl]ethyl acetate;dibromide	Investigative	44427862	C46H56Br2N4O6	920.8	CC(=O)OCC[N+]12CC[C@H]3[C@@H]1C[C@@H]4[C@@H]5[C@@H]3N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N([C@@H]5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CCOC(=O)C)C1=CC=CC=C1.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B4BIW7	10-Acetoxy-ginkgolide B	Investigative	44420842	C22H26O10	450.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](C(=O)OC6O4)OC(=O)C)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	B4BIW7	10-Acetoxy-ginkgolide B	Investigative	44420842	C22H26O10	450.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](C(=O)OC6O4)OC(=O)C)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B4ETX5	(1R,6R,8S,11S)-8-Tert-butyl-6,13-dimethoxy-2,4,14,17-tetraoxapentacyclo[8.5.2.0^{1,11}.0^{3,7}.0^{7,11}]heptadecane-5,15,16-trione	Investigative	44420857	C19H24O9	396.4	CC(C)(C)[C@@H]1CC2[C@]34C15[C@H](C(=O)OC5O[C@]3(C(=O)O2)C(=O)OC(C4)OC)OC	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	B4ETX5	(1R,6R,8S,11S)-8-Tert-butyl-6,13-dimethoxy-2,4,14,17-tetraoxapentacyclo[8.5.2.0^{1,11}.0^{3,7}.0^{7,11}]heptadecane-5,15,16-trione	Investigative	44420857	C19H24O9	396.4	CC(C)(C)[C@@H]1CC2[C@]34C15[C@H](C(=O)OC5O[C@]3(C(=O)O2)C(=O)OC(C4)OC)OC	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B5HGK1	(1S,6R,8S,9R,11S,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-5,15,18-trioxo-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecan-9-yl trifluoromethanesulfonate	Investigative	44420880	C21H23F3O13S	572.5	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@@]3([C@H]2O)C6([C@@H]([C@H]5OS(=O)(=O)C(F)(F)F)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	B5HGK1	(1S,6R,8S,9R,11S,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-5,15,18-trioxo-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecan-9-yl trifluoromethanesulfonate	Investigative	44420880	C21H23F3O13S	572.5	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@@]3([C@H]2O)C6([C@@H]([C@H]5OS(=O)(=O)C(F)(F)F)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B6DS0X	[20-[[Dimethyl-[(4-nitrophenyl)methyl]azaniumyl]methyl]-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(20),4,6,8,10,14,16,18-octaen-10-yl]methyl-dimethyl-[(4-nitrophenyl)methyl]azanium;dibromide	Investigative	17758335	C38H40Br2N6O4	804.6	C[N+](C)(CC1=CC=C(C=C1)[N+](=O)[O-])CC2=C3CN4C(=C(C5=CC=CC=C54)C[N+](C)(C)CC6=CC=C(C=C6)[N+](=O)[O-])CN3C7=CC=CC=C72.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B6UNE7	10-Methoxymethyloxy-ginkgolide A	Investigative	44420847	C22H28O10	452.5	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34[C@@]5(C2)[C@@H](C[C@H]([C@@]56[C@H](C(=O)O[C@H]6O3)OCOC)C(C)(C)C)C(=O)O4)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	B6UNE7	10-Methoxymethyloxy-ginkgolide A	Investigative	44420847	C22H28O10	452.5	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34[C@@]5(C2)[C@@H](C[C@H]([C@@]56[C@H](C(=O)O[C@H]6O3)OCOC)C(C)(C)C)C(=O)O4)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B71ORY	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione	Investigative	44420875	C20H24O11	440.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H]([C@@H]5O)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	B71ORY	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,9,12,17-tetrahydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione	Investigative	44420875	C20H24O11	440.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H]([C@@H]5O)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B83VWU	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Bis[(3,4-dimethoxyphenyl)methyl]-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dichloride	Investigative	44427868	C56H64Cl2N4O6	960	COC1=C(C=C(C=C1)C[N+]23CC[C@H]4[C@@H]2C[C@@H]5[C@@H]6[C@@H]4N([C@H]7[C@@H]8[C@H]9C[C@H]1[C@@]2([C@H]8N([C@@H]6OCC=C5C3)C3=CC=CC=C32)CC[N+]1(CC9=CCO7)CC1=CC(=C(C=C1)OC)OC)C1=CC=CC=C1)OC.[Cl-].[Cl-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	B9S5TL	(1R,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-24-Phenyl-15-prop-2-enyl-10,26-dioxa-8,24,31-triaza-15-azoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;bromide	Investigative	44427856	C41H47BrN4O2	707.7	C=CC[N+]12CC[C@H]3[C@@H]1C[C@@H]4[C@@H]5[C@@H]3N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N([C@@H]5OCC=C4C2)C2=CC=CC=C21)CCN9CC8=CCO6)C1=CC=CC=C1.[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BA20PH	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Dibenzyl-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427866	C52H56Br2N4O2	928.8	C1C[N+]2(CC3=CCO[C@@H]4[C@@H]5[C@H]3C[C@H]2[C@H]1[C@H]5N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=CC=C1)C1=CC=CC=C1)CC1=CC=CC=C1.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BA5OF9	(1R,6R,8S,11S,13S,16R,17R)-8-Tert-butyl-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-6,17-diol	Investigative	44420868	C20H30O6	366.4	C[C@@H]1CO[C@@H]2[C@]1([C@]34COC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](COC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BA5OF9	(1R,6R,8S,11S,13S,16R,17R)-8-Tert-butyl-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-6,17-diol	Investigative	44420868	C20H30O6	366.4	C[C@@H]1CO[C@@H]2[C@]1([C@]34COC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](COC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BD8H2U	1,23,14-Dianhydro-Ginkgolide C	Investigative	44420848	C20H20O9	404.4	CC1=C2C(=C[C@@]34[C@@]25C(=O)OC3[C@@H]([C@H](C46[C@H](C(=O)OC6O5)O)C(C)(C)C)O)OC1=O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BD8H2U	1,23,14-Dianhydro-Ginkgolide C	Investigative	44420848	C20H20O9	404.4	CC1=C2C(=C[C@@]34[C@@]25C(=O)OC3[C@@H]([C@H](C46[C@H](C(=O)OC6O5)O)C(C)(C)C)O)OC1=O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BE1W2K	Trimethyl-[[20-[(trimethylazaniumyl)methyl]-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(20),4,6,8,10,14,16,18-octaen-10-yl]methyl]azanium;diiodide	Investigative	44408895	C26H34I2N4	656.4	C[N+](C)(C)CC1=C2CN3C(=C(C4=CC=CC=C43)C[N+](C)(C)C)CN2C5=CC=CC=C51.[I-].[I-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BEK9S2	(1R,9R,18S,19S,21R,22R,23R,25R,32S,34R,35R,36S)-24-Phenyl-10,26-dioxa-8,15,24,31-tetraazaundecacyclo[29.5.2.0^{1,32}.0^{2,7}.0^{8,36}.0^{9,22}.0^{13,21}.0^{15,19}.0^{18,23}.0^{25,35}.0^{29,34}]octatriaconta-2,4,6,12,28-pentaene	Investigative	44427853	C38H42N4O2	586.8	C1CN2CC3=CCO[C@@H]4[C@@H]5[C@H]3C[C@H]2[C@H]1[C@H]5N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N4C2=CC=CC=C21)CCN9CC8=CCO6)C1=CC=CC=C1	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BEU4I5	(1S,6R,8S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,9,15,18-tetrone	Investigative	44420879	C20H22O11	438.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H](C5=O)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BEU4I5	(1S,6R,8S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,9,15,18-tetrone	Investigative	44420879	C20H22O11	438.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H](C5=O)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BHJ0F6	[(1R,6R,8S,11S,13S,16R,17S)-8-Tert-butyl-16-methyl-5,15,18-trioxo-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecan-6-yl] acetate	Investigative	44420843	C22H26O9	434.4	C[C@@H]1[C@H]2[C@H](C[C@@]34[C@@]25C(=O)OC3C[C@H](C46[C@H](C(=O)OC6O5)OC(=O)C)C(C)(C)C)OC1=O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BHJ0F6	[(1R,6R,8S,11S,13S,16R,17S)-8-Tert-butyl-16-methyl-5,15,18-trioxo-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecan-6-yl] acetate	Investigative	44420843	C22H26O9	434.4	C[C@@H]1[C@H]2[C@H](C[C@@]34[C@@]25C(=O)OC3C[C@H](C46[C@H](C(=O)OC6O5)OC(=O)C)C(C)(C)C)OC1=O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BHL1E2	(1S,2R,3S,6S,8S,10R)-10-Tert-butyl-2-hydroxy-3-methyl-5,13,15-trioxapentacyclo[7.5.2.0^{1,8}.0^{2,6}.0^{8,12}]hexadecane-4,14,16-trione	Investigative	44420854	C18H22O7	350.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C([C@@H](C5)C(C)(C)C)C(=O)O4)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BHL1E2	(1S,2R,3S,6S,8S,10R)-10-Tert-butyl-2-hydroxy-3-methyl-5,13,15-trioxapentacyclo[7.5.2.0^{1,8}.0^{2,6}.0^{8,12}]hexadecane-4,14,16-trione	Investigative	44420854	C18H22O7	350.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C([C@@H](C5)C(C)(C)C)C(=O)O4)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BHTQ95	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Bis[(4-bromophenyl)methyl]-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427870	C52H54Br4N4O2	1086.6	C1C[N+]2(CC3=CCO[C@@H]4[C@@H]5[C@H]3C[C@H]2[C@H]1[C@H]5N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=C(C=C1)Br)C1=CC=CC=C1)CC1=CC=C(C=C1)Br.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BIT3A1	(2E)-2-[(1S,9Z,11S,13S,17R,18R,20R,27S,29R,30R,31S)-14,26-Bis[(3,4-dimethoxyphenyl)methyl]-19-phenyl-21-oxa-8,19-diaza-14,26-diazoniadecacyclo[24.5.2.211,14.01,27.02,7.08,31.010,18.013,17.020,30.024,29]pentatriaconta-2,4,6,9,23-pentaen-35-ylidene]ethanol;dichloride	Investigative	44427881	C56H64Cl2N4O6	960	COC1=C(C=C(C=C1)C[N+]23CC[C@H]4[C@@H]2C[C@@H](/C(=C\\CO)/C3)/C/5=C/N6[C@H]7[C@H]8[C@H]9C[C@H]1[C@@]7(CC[N+]1(CC9=CCO[C@H]8N([C@H]45)C1=CC=CC=C1)CC1=CC(=C(C=C1)OC)OC)C1=CC=CC=C16)OC.[Cl-].[Cl-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BJ0P6F	Methyl 2-[(1R,6R,8S,11S,14R)-8-tert-butyl-6-hydroxy-5,15-dioxo-2,4,16-trioxapentacyclo[8.4.2.0^{1,11}.0^{3,7}.0^{7,11}]hexadecan-14-yl]propanoate	Investigative	44420865	C21H28O8	408.4	CC([C@H]1CC[C@@]23[C@@]14C(=O)OC2C[C@H](C35[C@H](C(=O)OC5O4)O)C(C)(C)C)C(=O)OC	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BJ0P6F	Methyl 2-[(1R,6R,8S,11S,14R)-8-tert-butyl-6-hydroxy-5,15-dioxo-2,4,16-trioxapentacyclo[8.4.2.0^{1,11}.0^{3,7}.0^{7,11}]hexadecan-14-yl]propanoate	Investigative	44420865	C21H28O8	408.4	CC([C@H]1CC[C@@]23[C@@]14C(=O)OC2C[C@H](C35[C@H](C(=O)OC5O4)O)C(C)(C)C)C(=O)OC	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BJ1U5P	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Di(cyclohex-2-en-1-yl)-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427864	C50H60Br2N4O2	908.8	C1CC=CC(C1)[N+]23CC[C@H]4[C@@H]2C[C@@H]5[C@@H]6[C@@H]4N([C@H]7[C@@H]8[C@H]9C[C@H]1[C@@]2([C@H]8N([C@@H]6OCC=C5C3)C3=CC=CC=C32)CC[N+]1(CC9=CCO7)C1CCCC=C1)C1=CC=CC=C1.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BJ2M5B	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-5,15,18-trioxo-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecan-9-yl 2-phenylacetate	Investigative	44420872	C28H30O12	558.5	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H]([C@@H]5OC(=O)CC7=CC=CC=C7)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BJ2M5B	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-5,15,18-trioxo-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecan-9-yl 2-phenylacetate	Investigative	44420872	C28H30O12	558.5	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H]([C@@H]5OC(=O)CC7=CC=CC=C7)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BK2E1J	[20-[[Dimethyl(prop-2-enyl)azaniumyl]methyl]-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icosa-1(20),4,6,8,10,14,16,18-octaen-10-yl]methyl-dimethyl-prop-2-enylazanium;dibromide	Investigative	44408940	C30H38Br2N4	614.5	C[N+](C)(CC=C)CC1=C2CN3C(=C(C4=CC=CC=C43)C[N+](C)(C)CC=C)CN2C5=CC=CC=C51.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-3	BKM4G0	5-[(1H-Indol-3-yl)methylidene]-1,3-dimethylimidazolidine-2,4-dione	Investigative	135753564	C14H13N3O2	255.27	CN1C(=C(N(C1=O)C)O)/C=C/2\\C=NC3=CC=CC=C32	IC50 = 67000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BL1F9Q	Methyl (2R)-2-[(1S,2R,3S,6S,8S,10S)-10-tert-butyl-2-hydroxy-16-methoxy-3-methyl-4,14-dioxo-5,13,15-trioxapentacyclo[7.5.2.0^{1,8}.0^{2,6}.0^{8,12}]hexadecan-9-yl]-2-methoxyacetate	Investigative	44420851	C23H32O10	468.5	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C([C@@H](C5)C(C)(C)C)(C(O4)OC)[C@H](C(=O)OC)OC)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BL1F9Q	Methyl (2R)-2-[(1S,2R,3S,6S,8S,10S)-10-tert-butyl-2-hydroxy-16-methoxy-3-methyl-4,14-dioxo-5,13,15-trioxapentacyclo[7.5.2.0^{1,8}.0^{2,6}.0^{8,12}]hexadecan-9-yl]-2-methoxyacetate	Investigative	44420851	C23H32O10	468.5	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C([C@@H](C5)C(C)(C)C)(C(O4)OC)[C@H](C(=O)OC)OC)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BMB03R	2-[(1R,11S,13S,17S,18R,20R,27S,29R,30R,31S,35E)-19-Phenyl-21-oxa-8,14,19,26-tetraazadecacyclo[24.5.2.2^{11,14}.0^{1,27}.0^{2,7}.0^{8,31}.0^{10,18}.0^{13,17}.0^{20,30}.0^{24,29}]pentatriaconta-2,4,6,9,23-pentaen-35-ylidene]ethan-1-ol	Investigative	44427876	C38H42N4O2	586.8	C1CN2C/C(=C/CO)/[C@@H]\\3C[C@H]2[C@H]1[C@@H]4/C3=C\\N5[C@H]6[C@H]7[C@H]8C[C@H]9[C@@]6(CCN9CC8=CCO[C@H]7N4C1=CC=CC=C1)C1=CC=CC=C15	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BN0W7L	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-9-(methylamino)-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione	Investigative	44420870	C21H27NO10	453.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H]([C@@H]5NC)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BN0W7L	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-9-(methylamino)-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione	Investigative	44420870	C21H27NO10	453.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H]([C@@H]5NC)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BND69V	(2E)-2-[(1S,9Z,11S,13S,17R,18R,20R,27S,29R,30R,31S)-14,26-Di(cyclohex-2-en-1-yl)-19-phenyl-21-oxa-8,19-diaza-14,26-diazoniadecacyclo[24.5.2.211,14.01,27.02,7.08,31.010,18.013,17.020,30.024,29]pentatriaconta-2,4,6,9,23-pentaen-35-ylidene]ethanol;dibromide	Investigative	44427879	C50H60Br2N4O2	908.8	C1CC=CC(C1)[N+]23CC[C@H]4[C@@H]2C[C@@H](/C(=C\\CO)/C3)/C/5=C/N6[C@H]7[C@H]8[C@H]9C[C@H]1[C@@]7(CC[N+]1(CC9=CCO[C@H]8N([C@H]45)C1=CC=CC=C1)C1CCCC=C1)C1=CC=CC=C16.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BOHE83	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Bis[(4-nitrophenyl)methyl]-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427872	C52H54Br2N6O6	1018.8	C1C[N+]2(CC3=CCO[C@@H]4[C@@H]5[C@H]3C[C@H]2[C@H]1[C@H]5N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=C(C=C1)[N+](=O)[O-])C1=CC=CC=C1)CC1=CC=C(C=C1)[N+](=O)[O-].[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BQG2Z4	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-24-Phenyl-15,31-bis(prop-2-enyl)-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427858	C44H52Br2N4O2	828.7	C=CC[N+]12CC[C@H]3[C@@H]1C[C@@H]4[C@@H]5[C@@H]3N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N([C@@H]5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC=C)C1=CC=CC=C1.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BR4EJ5	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-5,15,18-trioxo-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecan-9-yl acetate	Investigative	44420876	C22H26O12	482.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H]([C@@H]5OC(=O)C)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BR4EJ5	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-6,12,17-trihydroxy-16-methyl-5,15,18-trioxo-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecan-9-yl acetate	Investigative	44420876	C22H26O12	482.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3([C@H]2O)C6([C@@H]([C@@H]5OC(=O)C)C(C)(C)C)[C@H](C(=O)OC6O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BRT8J6	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Dimethyl-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;diiodide	Investigative	44427854	C40H48I2N4O2	870.6	C[N+]12CC[C@H]3[C@@H]1C[C@@H]4[C@@H]5[C@@H]3N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N([C@@H]5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)C)C1=CC=CC=C1.[I-].[I-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BS1Z9N	(1S,8S,11S,13S,16S,17R)-8-Tert-butyl-17-hydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,6,15,18-tetrone	Investigative	44420840	C20H22O9	406.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)C(O4)OC(=O)C6=O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BS1Z9N	(1S,8S,11S,13S,16S,17R)-8-Tert-butyl-17-hydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,6,15,18-tetrone	Investigative	44420840	C20H22O9	406.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@]34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)C(O4)OC(=O)C6=O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BS34NT	(2E)-2-[(9Z,11S,13S,17S,25Z,27S,33S,35S,36S,38E)-38-(2-Hydroxyethylidene)-14,30-dimethyl-8,24-diaza-14,30-diazoniaundecacyclo[25.5.2.211,14.11,26.110,17.02,7.013,17.018,23.030,33.08,35.024,36]octatriaconta-2,4,6,9,18,20,22,25-octaen-28-ylidene]ethanol;dichloride	Investigative	44427885	C40H46Cl2N4O2	685.7	C[N+]12CC[C@@]34[C@@H]1C[C@@H](/C(=C\\CO)/C2)/C/5=C/N6[C@H]7/C(=C\\N([C@@H]53)C8=CC=CC=C48)/[C@H]\\9C[C@H]1C7(CC[N+]1(C/C9=C/CO)C)C1=CC=CC=C16.[Cl-].[Cl-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BS5LV9	(1R,2R,3S,6S,8S,10R,11R)-10-Tert-butyl-2,11,16-trihydroxy-3-methyl-5,13,15-trioxapentacyclo[7.5.2.0^{1,8}.0^{2,6}.0^{8,12}]hexadecane-4,14-dione	Investigative	44420852	C18H24O8	368.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)OC5[C@]3(C2)C([C@@H]([C@H]5O)C(C)(C)C)C(O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BS5LV9	(1R,2R,3S,6S,8S,10R,11R)-10-Tert-butyl-2,11,16-trihydroxy-3-methyl-5,13,15-trioxapentacyclo[7.5.2.0^{1,8}.0^{2,6}.0^{8,12}]hexadecane-4,14-dione	Investigative	44420852	C18H24O8	368.4	C[C@@H]1C(=O)O[C@@H]2[C@]1([C@@]34C(=O)OC5[C@]3(C2)C([C@@H]([C@H]5O)C(C)(C)C)C(O4)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BSXN01	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-9-(ethylamino)-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione	Investigative	44420871	C22H29NO10	467.5	CCN[C@H]1[C@H](C23[C@H](C(=O)OC2O[C@]45[C@@]3(C1OC4=O)[C@H]([C@H]6[C@@]5([C@@H](C(=O)O6)C)O)O)O)C(C)(C)C	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BSXN01	(1S,6R,8S,9S,11R,12R,13S,16S,17R)-8-Tert-butyl-9-(ethylamino)-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione	Investigative	44420871	C22H29NO10	467.5	CCN[C@H]1[C@H](C23[C@H](C(=O)OC2O[C@]45[C@@]3(C1OC4=O)[C@H]([C@H]6[C@@]5([C@@H](C(=O)O6)C)O)O)O)C(C)(C)C	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BUK9R2	(6R,8S,11S,16R,17S)-8-Tert-butyl-6,16,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione	Investigative	44420839	C20H24O10	424.4	C[C@@]1(C(=O)OC2[C@]1(C34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](C(=O)OC6O4)O)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BUK9R2	(6R,8S,11S,16R,17S)-8-Tert-butyl-6,16,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.0^{1,11}.0^{3,7}.0^{7,11}.0^{13,17}]nonadecane-5,15,18-trione	Investigative	44420839	C20H24O10	424.4	C[C@@]1(C(=O)OC2[C@]1(C34C(=O)OC5[C@]3(C2)C6([C@@H](C5)C(C)(C)C)[C@H](C(=O)OC6O4)O)O)O	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BW2SH0	(2E)-2-[(1S,9Z,11S,13S,14R,17S,25Z,27S,33S,35S,36S,38E)-38-(2-Hydroxyethylidene)-14,30-bis(prop-2-enyl)-8,24-diaza-14,30-diazoniaundecacyclo[25.5.2.211,14.11,26.110,17.02,7.013,17.018,23.030,33.08,35.024,36]octatriaconta-2,4,6,9,18,20,22,25-octaen-28-ylidene]ethanol	Investigative	90659973	C44H50N4O2+2	666.9	C=CC[N@@+]12CC[C@@]34[C@@H]1C[C@@H](/C(=C\\CO)/C2)/C/5=C/N6[C@H]7/C(=C\\N([C@@H]53)C8=CC=CC=C48)/[C@H]\\9C[C@H]1[C@@]7(CC[N+]1(C/C9=C/CO)CC=C)C1=CC=CC=C16	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BW9LK2	(1S,9R,18R,19S,21R,22R,23R,25R,32S,34R,35R,36S)-15,31-Bis[(E)-but-2-enyl]-24-phenyl-10,26-dioxa-8,24-diaza-15,31-diazoniaundecacyclo[29.5.2.01,32.02,7.08,36.09,22.013,21.015,19.018,23.025,35.029,34]octatriaconta-2,4,6,12,28-pentaene;dibromide	Investigative	44427860	C46H56Br2N4O2	856.8	C/C=C/C[N+]12CC[C@H]3[C@@H]1C[C@@H]4[C@@H]5[C@@H]3N([C@H]6[C@@H]7[C@H]8C[C@H]9[C@@]1([C@H]7N([C@@H]5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)C/C=C/C)C1=CC=CC=C1.[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BXIS94	(1R,6R,8S,11R)-8-Tert-butyl-13-methoxy-5,15,16-trioxo-2,4,14,17-tetraoxapentacyclo[8.5.2.0^{1,11}.0^{3,7}.0^{7,11}]heptadecan-6-yl acetate	Investigative	44420856	C20H24O10	424.4	CC(=O)O[C@H]1C(=O)OC2C13[C@@H](CC4[C@@]35CC(OC(=O)[C@]5(O2)C(=O)O4)OC)C(C)(C)C	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-2	BXIS94	(1R,6R,8S,11R)-8-Tert-butyl-13-methoxy-5,15,16-trioxo-2,4,14,17-tetraoxapentacyclo[8.5.2.0^{1,11}.0^{3,7}.0^{7,11}]heptadecan-6-yl acetate	Investigative	44420856	C20H24O10	424.4	CC(=O)O[C@H]1C(=O)OC2C13[C@@H](CC4[C@@]35CC(OC(=O)[C@]5(O2)C(=O)O4)OC)C(C)(C)C	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BZ1GQ7	(2E)-2-[(1S,9Z,11S,13S,17R,18R,20R,27S,29R,30R,31S)-14,26-Dimethyl-19-phenyl-21-oxa-8,19-diaza-14,26-diazoniadecacyclo[24.5.2.211,14.01,27.02,7.08,31.010,18.013,17.020,30.024,29]pentatriaconta-2,4,6,9,23-pentaen-35-ylidene]ethanol;diiodide	Investigative	44427877	C40H48I2N4O2	870.6	C[N+]12CC[C@H]3[C@@H]1C[C@@H](/C(=C\\CO)/C2)/C/4=C/N5[C@H]6[C@H]7[C@H]8C[C@H]9[C@@]6(CC[N+]9(CC8=CCO[C@H]7N([C@H]34)C1=CC=CC=C1)C)C1=CC=CC=C15.[I-].[I-]	IC50 ~ 100000 nM	Poor binder
T55285	Glycine receptor subunit alpha-1	BZL54E	(2E)-2-[(1S,9Z,11S,13S,18R,20R,27S,29R,30R,31S)-14,26-Bis[(4-nitrophenyl)methyl]-19-phenyl-21-oxa-8,19-diaza-14,26-diazoniadecacyclo[24.5.2.211,14.01,27.02,7.08,31.010,18.013,17.020,30.024,29]pentatriaconta-2,4,6,9,23-pentaen-35-ylidene]ethanol;dibromide	Investigative	44427883	C52H54Br2N6O6	1018.8	C1C[N+]2(C/C(=C/CO)/[C@@H]\\3C[C@H]2C1[C@@H]4/C3=C\\N5[C@H]6[C@H]7[C@H]8C[C@H]9[C@@]6(CC[N+]9(CC8=CCO[C@H]7N4C1=CC=CC=C1)CC1=CC=C(C=C1)[N+](=O)[O-])C1=CC=CC=C15)CC1=CC=C(C=C1)[N+](=O)[O-].[Br-].[Br-]	IC50 ~ 100000 nM	Poor binder